SEC Filing Summary: PharmAthene, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by PharmAthene, Inc. on May 28, 2013, reporting events occurring on May 26, 2013. The filing serves to incorporate by reference a press release issued by the Company on that date. Note: The request metadata referenced "Altimmune, Inc.", but the filing text explicitly identifies the registrant as PharmAthene, Inc.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain a financial statement or earnings summary.
Material Changes
The filing discloses the issuance of a press release (Exhibit 99.1) as the material event. The content of the press release is not included in the provided text, so specific operational or financial changes cannot be summarized.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. These items would be contained within the attached press release (Exhibit 99.1), which is not part of the input text.
Investor Verification Checklist
- Verify the content of the press release dated May 26, 2013 (Exhibit 99.1) to understand the specific event being reported.
- Confirm the correct registrant name is PharmAthene, Inc., not Altimmune, Inc.
- Review subsequent filings for any financial impact resulting from the event disclosed in this 8-K.